Murri, R <br/><br/>
Intravenous drug use, relationship with providers, and stage of HIV disease influence the prescription rates of protease inhibitors.  [electronic resource] 

 -  Journal of acquired immune deficiency syndromes (1999)  Dec 1999 
 - 461-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1525-4135 
<br/><br/><label>Standard No.: </label>10.1097/00126334-199912150-00006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-HIV Agents--therapeutic use<br/>Cohort Studies<br/>Cross-Sectional Studies<br/>Drug Prescriptions<br/>Female<br/>HIV Infections--drug therapy<br/>HIV Protease Inhibitors--therapeutic use<br/>Humans<br/>Male<br/>Physician-Patient Relations<br/>Substance Abuse, Intravenous